The second annual DRNS conference, supported by the Society for the Study of Addiction, will focus on the knowledge, skills and issues relevant to the future of drugs research in Scotland and the rest of the UK.
In recent years, the tobacco pandemic’s magnitude and trajectory has shifted away from high-income countries to low- and middle-income countries and so have the tobacco industry’s marketing efforts and tactics.
Research suggests that Sub-Saharan Africa is expected to face the largest growth in tobacco use in the world.
Deaths in England directly caused by alcohol rose by 11% between 2006 and 2017. During the same period, hospital admissions in which alcohol misuse was a primary factor increased by 17%.
This publication provides an update on drug-related deaths in Europe, presenting and analysing the latest data and trends in drug-induced deaths and overall mortality among high-risk drug users in the European Union and beyond.
The consumption of alcohol, tobacco and other drugs is a major cause of preventable disease and illness in Australia.
The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) has published the latest European Drug Report, which provides an analysis of the latest data on the drug trends across the European Union, Norway and Turkey.
This episode focuses on data released ahead of the first anniversary of the Scottish Government's flagship health policy of minimum unit pricing.
The majority of existing knowledge on patterns of alcohol consumption is based on retrospective-recall methodologies.
These are cost-efficient and convenient but are limited in their capacity to record data on the circumstances of alcohol consumption as they emerge in time and space.